|
WO2003040165A2
(en)
|
2000-10-19 |
2003-05-15 |
Epimmune Inc. |
Hla class i and ii binding peptides and their uses
|
|
FR2711670B1
(fr)
|
1993-10-22 |
1996-01-12 |
Pasteur Institut |
Vecteur nucléotidique, composition le contenant et vaccin pour l'immunisation à l'encontre d'une hépatite.
|
|
US6995008B1
(en)
*
|
1994-03-07 |
2006-02-07 |
Merck & Co., Inc. |
Coordinate in vivo gene expression
|
|
US6727230B1
(en)
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US5736524A
(en)
*
|
1994-11-14 |
1998-04-07 |
Merck & Co.,. Inc. |
Polynucleotide tuberculosis vaccine
|
|
FR2732895B1
(fr)
*
|
1995-04-11 |
1997-05-16 |
Pasteur Merieux Serums Vacc |
Utilisation d'un compose amphipathique cationique comme agent de transfection, comme adjuvant de vaccin, ou comme medicament
|
|
US6458366B1
(en)
|
1995-09-01 |
2002-10-01 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6338852B1
(en)
|
1995-09-01 |
2002-01-15 |
Corixa Corporation |
Compounds and methods for diagnosis of tuberculosis
|
|
US6290969B1
(en)
|
1995-09-01 |
2001-09-18 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US6592877B1
(en)
|
1995-09-01 |
2003-07-15 |
Corixa Corporation |
Compounds and methods for immunotherapy and diagnosis of tuberculosis
|
|
US20070021364A1
(en)
*
|
1995-12-13 |
2007-01-25 |
Hans Herweijer |
Methods for genetic immunization
|
|
US20020165183A1
(en)
*
|
1999-11-29 |
2002-11-07 |
Hans Herweijer |
Methods for genetic immunization
|
|
ZA973642B
(en)
*
|
1996-04-26 |
1997-11-25 |
Merck & Co Inc |
DNA vaccine formulations.
|
|
US5846946A
(en)
*
|
1996-06-14 |
1998-12-08 |
Pasteur Merieux Serums Et Vaccins |
Compositions and methods for administering Borrelia DNA
|
|
FR2751228B1
(fr)
*
|
1996-07-19 |
1998-11-20 |
Rhone Merieux |
Vaccin polynucleotidique bovin pour voie intradermique
|
|
FR2751225B1
(fr)
*
|
1996-07-19 |
1998-11-27 |
Rhone Merieux |
Formule de vaccin polynucleotidique aviaire
|
|
EP2298900A1
(de)
*
|
1996-09-17 |
2011-03-23 |
Novartis Vaccines and Diagnostics, Inc. |
Zusammensetzungen und Verfahren zur Behandlung intrazellulärer Erkrankungen
|
|
US6797276B1
(en)
|
1996-11-14 |
2004-09-28 |
The United States Of America As Represented By The Secretary Of The Army |
Use of penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response
|
|
US5980898A
(en)
*
|
1996-11-14 |
1999-11-09 |
The United States Of America As Represented By The U.S. Army Medical Research & Material Command |
Adjuvant for transcutaneous immunization
|
|
US20060002959A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Government Of The United States |
Skin-sctive adjuvants for transcutaneous immuization
|
|
US20060002949A1
(en)
*
|
1996-11-14 |
2006-01-05 |
Army Govt. Of The Usa, As Rep. By Secretary Of The Office Of The Command Judge Advocate, Hq Usamrmc. |
Transcutaneous immunization without heterologous adjuvant
|
|
WO1998035029A1
(en)
*
|
1997-02-07 |
1998-08-13 |
Vanderbilt University |
Synthetic genes for recombinant mycobacterium proteins
|
|
US6261281B1
(en)
*
|
1997-04-03 |
2001-07-17 |
Electrofect As |
Method for genetic immunization and introduction of molecules into skeletal muscle and immune cells
|
|
US20040258703A1
(en)
*
|
1997-11-14 |
2004-12-23 |
The Government Of The Us, As Represented By The Secretary Of The Army |
Skin-active adjuvants for transcutaneous immunization
|
|
CA2328180A1
(en)
*
|
1998-04-14 |
1999-10-21 |
Merck & Co., Inc. |
Needleless administration of polynucleotide formulations
|
|
DE69941545D1
(de)
*
|
1998-11-04 |
2009-11-26 |
Isis Innovation |
Tuberkulose diagnose test
|
|
US8197461B1
(en)
|
1998-12-04 |
2012-06-12 |
Durect Corporation |
Controlled release system for delivering therapeutic agents into the inner ear
|
|
US6465633B1
(en)
|
1998-12-24 |
2002-10-15 |
Corixa Corporation |
Compositions and methods of their use in the treatment, prevention and diagnosis of tuberculosis
|
|
US7022320B1
(en)
|
1999-02-09 |
2006-04-04 |
Powderject Vaccines, Inc. |
Mycobacterium tuberculosis immunization
|
|
WO2000061184A2
(en)
*
|
1999-04-08 |
2000-10-19 |
Glenn Gregory M |
Dry formulation for transcutaneous immunization
|
|
US20040258672A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Graft acceptance through manipulation of thymic regeneration
|
|
US20070274946A1
(en)
*
|
1999-04-15 |
2007-11-29 |
Norwood Immunoloty, Ltd. |
Tolerance to Graft Prior to Thymic Reactivation
|
|
US20040265285A1
(en)
*
|
1999-04-15 |
2004-12-30 |
Monash University |
Normalization of defective T cell responsiveness through manipulation of thymic regeneration
|
|
AUPR074500A0
(en)
*
|
2000-10-13 |
2000-11-09 |
Monash University |
Treatment of t cell disorders
|
|
US20040259803A1
(en)
*
|
1999-04-15 |
2004-12-23 |
Monash University |
Disease prevention by reactivation of the thymus
|
|
US20040241842A1
(en)
*
|
1999-04-15 |
2004-12-02 |
Monash University |
Stimulation of thymus for vaccination development
|
|
US20050020524A1
(en)
*
|
1999-04-15 |
2005-01-27 |
Monash University |
Hematopoietic stem cell gene therapy
|
|
EP1194449B1
(de)
*
|
1999-06-28 |
2010-09-22 |
Oklahoma Medical Research Foundation |
Inhibitoren des memapsin 2 und ihre verwendung
|
|
US6514948B1
(en)
*
|
1999-07-02 |
2003-02-04 |
The Regents Of The University Of California |
Method for enhancing an immune response
|
|
US20050100928A1
(en)
*
|
1999-09-16 |
2005-05-12 |
Zycos Inc., A Delaware Corporation |
Nucleic acids encoding polyepitope polypeptides
|
|
EP1228237A1
(de)
*
|
1999-11-01 |
2002-08-07 |
Chiron Corporation |
Expressionsvektoren, transfektionssysteme, und verfahren zur verwendung
|
|
EP2177534A3
(de)
|
1999-11-18 |
2010-07-14 |
Pharmexa Inc. |
Heteroklitische Analoga von Klasse-i Epitopen
|
|
EP1244687A4
(de)
*
|
1999-12-22 |
2005-06-15 |
Univ Ohio State Res Found |
Schutzma nahmen gegen die tödliche infektion durch i bacillus anthracis
|
|
FR2804028B1
(fr)
*
|
2000-01-21 |
2004-06-04 |
Merial Sas |
Vaccins adn ameliores pour animaux de rente
|
|
US6552006B2
(en)
|
2000-01-31 |
2003-04-22 |
The Regents Of The University Of California |
Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen
|
|
US20030130217A1
(en)
*
|
2000-02-23 |
2003-07-10 |
Eyal Raz |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
|
CA2399550A1
(en)
|
2000-02-23 |
2001-08-30 |
The Regents Of The University Of California |
Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
|
|
EP1278541A1
(de)
*
|
2000-04-28 |
2003-01-29 |
The Government of The United States of America, as represented by The Department of Health and Human Services |
Verbesserung der immunogenität bei der verwendung einer kombination von dns und vacciniavirus-vektor impfstoffen
|
|
US6590087B1
(en)
*
|
2000-05-25 |
2003-07-08 |
Johns Hopkins University |
whmD, an essential cell division gene from mycobacteria
|
|
WO2002004018A2
(en)
*
|
2000-07-10 |
2002-01-17 |
Colorado State University Research Foundation |
Mid-life vaccine and methods for boosting anti-mycobacterial immunity
|
|
DE60138465D1
(de)
|
2000-07-12 |
2009-06-04 |
Agensys Inc |
Neues tumor antigen das für diagnose und therapie von blasen-, eierstock-, lungen- und nierenkrebs verwendet werden kann
|
|
EP2022797A3
(de)
|
2000-08-28 |
2011-11-09 |
Agensys, Inc. |
Nukleinsäure und entsprechendes Protein mit der Bezeichnung 85P1B3 für die Behandlung und den Nachweis von Krebs
|
|
US20060088512A1
(en)
*
|
2001-10-15 |
2006-04-27 |
Monash University |
Treatment of T cell disorders
|
|
US7829084B2
(en)
|
2001-01-17 |
2010-11-09 |
Trubion Pharmaceuticals, Inc. |
Binding constructs and methods for use thereof
|
|
US7754208B2
(en)
|
2001-01-17 |
2010-07-13 |
Trubion Pharmaceuticals, Inc. |
Binding domain-immunoglobulin fusion proteins
|
|
EP1372708B1
(de)
*
|
2001-02-13 |
2008-06-18 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY OF THE ARMY |
Impstoffe zur transkutanen immunisierung gegen reisediarrhö
|
|
US7491394B2
(en)
|
2001-02-15 |
2009-02-17 |
The Board Of Trustees Of The University Of Illinois |
Cytotoxic factors for modulating cell death
|
|
US6924358B2
(en)
|
2001-03-05 |
2005-08-02 |
Agensys, Inc. |
121P1F1: a tissue specific protein highly expressed in various cancers
|
|
US7271240B2
(en)
|
2001-03-14 |
2007-09-18 |
Agensys, Inc. |
125P5C8: a tissue specific protein highly expressed in various cancers
|
|
US20040242523A1
(en)
*
|
2003-03-06 |
2004-12-02 |
Ana-Farber Cancer Institue And The Univiersity Of Chicago |
Chemo-inducible cancer gene therapy
|
|
US8034791B2
(en)
|
2001-04-06 |
2011-10-11 |
The University Of Chicago |
Activation of Egr-1 promoter by DNA damaging chemotherapeutics
|
|
ATE541937T1
(de)
*
|
2001-04-06 |
2012-02-15 |
Univ Chicago |
Chemotherapeutische einleitung der egr-1-promoter-aktivität in gentherapie
|
|
US20030191073A1
(en)
|
2001-11-07 |
2003-10-09 |
Challita-Eid Pia M. |
Nucleic acid and corresponding protein entitled 161P2F10B useful in treatment and detection of cancer
|
|
EP1573024A4
(de)
|
2001-04-10 |
2007-08-29 |
Agensys Inc |
Nukleinsäuren und diesen entprechende, für die behandlung und den nachweis verschiedener krebserkrankungen geeignete proteine
|
|
US7013940B2
(en)
*
|
2001-04-19 |
2006-03-21 |
Michelin Recherche Et Technique S.A. |
Device for attenuating cavity noise in a tire and wheel
|
|
JP4338402B2
(ja)
|
2001-05-22 |
2009-10-07 |
ユニバーシティ オブ シカゴ |
N4ウイルス一本鎖dna依存的rnaポリメラーゼ
|
|
WO2003015716A2
(en)
*
|
2001-08-13 |
2003-02-27 |
Ige Therapeutics, Inc. |
Immunoglobulin e vaccines and methods of use thereof
|
|
WO2003022995A2
(en)
|
2001-09-06 |
2003-03-20 |
Agensys, Inc. |
Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
|
|
AU2002348417B9
(en)
*
|
2001-10-26 |
2010-02-04 |
Baylor College Of Medicine |
A composition and method to alter lean body mass and bone properties in a subject
|
|
AR037778A1
(es)
|
2001-12-11 |
2004-12-01 |
Advisys Inc |
Suplementacion mediada por plasmido para el tratamiento de sujetos cronicamente enfermos
|
|
JP2005527490A
(ja)
*
|
2002-01-18 |
2005-09-15 |
イノヴィオ アーエス |
筋肉内投与のための二重特異性抗体dna構築物
|
|
US20030199012A1
(en)
*
|
2002-02-01 |
2003-10-23 |
Ho John L. |
Compositions and methods for treatment of infectious and inflammatory diseases
|
|
US20060009409A1
(en)
|
2002-02-01 |
2006-01-12 |
Woolf Tod M |
Double-stranded oligonucleotides
|
|
US20030166282A1
(en)
|
2002-02-01 |
2003-09-04 |
David Brown |
High potency siRNAS for reducing the expression of target genes
|
|
US20050267025A1
(en)
*
|
2002-02-01 |
2005-12-01 |
Ho John L |
Compositions and methods for treatment of infectious and inflammatory diseases
|
|
EP1478656B1
(de)
*
|
2002-02-01 |
2009-09-16 |
Life Technologies Corporation |
Oligonukleotidzusammensetzungen mit verbesserter effizienz
|
|
US20070037769A1
(en)
*
|
2003-03-14 |
2007-02-15 |
Multicell Immunotherapeutics, Inc. |
Compositions and methods to treat and control tumors by loading antigen presenting cells
|
|
EP2258712A3
(de)
|
2002-03-15 |
2011-05-04 |
Multicell Immunotherapeutics, Inc. |
Zusammensetzungen und Verfahren zur Einleitung bzw. Verstärkung von Antikörper- und Haupthistokompatibilität-Klasse-I- oder-Klasse-II-beschränkten T-Zell-Reaktionen unter Anwendung von Immunmodulierenden, nicht-codierenden RNA-Motiven
|
|
AU2003218181A1
(en)
*
|
2002-03-15 |
2003-09-29 |
Multicell Immunotherapeutics, Inc. |
Immunostimulatory double stranded RNA and methods of inducing, enhancing or modulating the immune response
|
|
US7078037B2
(en)
*
|
2002-04-19 |
2006-07-18 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections
|
|
AU2003301841A1
(en)
*
|
2002-05-01 |
2004-06-07 |
National Institutes Of Health |
Immunotherapy regimens in hiv-infected patients
|
|
AU2003274463B2
(en)
|
2002-06-10 |
2009-10-29 |
University Of Rochester |
Gene differentially expressed in breast and bladder cancer and encoded polypeptides
|
|
US20090110702A1
(en)
*
|
2002-07-12 |
2009-04-30 |
The Johns Hopkins University |
Mesothelin Vaccines and Model Systems and Control of Tumors
|
|
US9200036B2
(en)
|
2002-07-12 |
2015-12-01 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
US20050175625A1
(en)
*
|
2002-07-12 |
2005-08-11 |
The Johns Hopkins University |
Mesothelin vaccines and model systems
|
|
EP1636561B1
(de)
|
2002-07-15 |
2011-02-09 |
Board Of Regents, The University Of Texas System |
Screening kombinatorischer proteinbibliotheken mittels periplasmatischer expression
|
|
US20040029275A1
(en)
*
|
2002-08-10 |
2004-02-12 |
David Brown |
Methods and compositions for reducing target gene expression using cocktails of siRNAs or constructs expressing siRNAs
|
|
WO2004014314A2
(en)
|
2002-08-12 |
2004-02-19 |
David Kirn |
Methods and compositions concerning poxviruses and cancer
|
|
US20040081653A1
(en)
|
2002-08-16 |
2004-04-29 |
Raitano Arthur B. |
Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer
|
|
AU2003284239B2
(en)
*
|
2002-10-21 |
2008-08-21 |
Eisai Inc. |
Compositions and methods for treating human papillomavirus-mediated disease
|
|
AU2002352976B2
(en)
|
2002-11-27 |
2007-11-08 |
Agensys, Inc. |
Nucleic acid corresponding protein entitled 24P4C12 useful in treatment and detection of cancer
|
|
EP1903056A3
(de)
|
2002-12-10 |
2008-05-07 |
Idm Pharma, Inc. |
HLA-A1, -A2, -A3, -A24, -B7 and -B44 bindende Peptide die Tumorassoziiert-Antigen Epitopen enthalten, und Zusammensetzungen davon
|
|
RU2242245C2
(ru)
*
|
2003-01-10 |
2004-12-20 |
Государственный научный центр вирусологии и биотехнологии "Вектор" |
Искусственные микобактериальные частицы и противотуберкулезная вакцинная композиция на их основе
|
|
CA2860151A1
(en)
|
2003-02-10 |
2004-08-26 |
Agensys, Inc. |
Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
|
|
US7262027B2
(en)
*
|
2003-03-14 |
2007-08-28 |
Medical College Of Ohio |
Polypeptide and DNA immunization against Coccidioides spp. infections
|
|
JP2006522806A
(ja)
*
|
2003-03-26 |
2006-10-05 |
マルチセル・イミュノセラピューティクス,インコーポレイテッド |
細胞死及び/又はアポトーシスを誘導するための、選択されたrnaモチーフ
|
|
TW200424214A
(en)
*
|
2003-04-21 |
2004-11-16 |
Advisys Inc |
Plasmid mediated GHRH supplementation for renal failures
|
|
WO2004105681A2
(en)
*
|
2003-04-28 |
2004-12-09 |
Innogenetics N.V. |
Cd4+ human papillomavirus (hpv) epitopes
|
|
AU2004263823B2
(en)
|
2003-05-30 |
2008-09-18 |
Agensys, Inc. |
Prostate stem cell antigen (PSCA) variants and subsequences thereof
|
|
US20060240039A1
(en)
*
|
2003-06-13 |
2006-10-26 |
Isis Innovation Limited |
Vaccines
|
|
US20070224615A1
(en)
*
|
2003-07-09 |
2007-09-27 |
Invitrogen Corporation |
Methods for assaying protein-protein interactions
|
|
CN1894581B
(zh)
|
2003-07-09 |
2012-02-01 |
生命技术公司 |
检测蛋白-蛋白相互作用的方法
|
|
ATE557099T1
(de)
*
|
2003-09-05 |
2012-05-15 |
Genencor Int |
Hpv cd8+ t-zell-epitope
|
|
US20080279812A1
(en)
*
|
2003-12-05 |
2008-11-13 |
Norwood Immunology, Ltd. |
Disease Prevention and Vaccination Prior to Thymic Reactivation
|
|
RU2262351C1
(ru)
*
|
2003-12-26 |
2005-10-20 |
ООО "Фирма "БиоМедИнвест" |
Вакцинная композиция для профилактики и лечения туберкулезной инфекции и генетические конструкции для получения действующих компонентов этой композиции
|
|
ATE555127T1
(de)
*
|
2004-02-11 |
2012-05-15 |
Angeletti P Ist Richerche Bio |
Fusionsproteine des karzinomembryonalen antigens und deren verwendungen
|
|
US20070287150A1
(en)
*
|
2004-03-18 |
2007-12-13 |
Rohrschneider Larry R |
Methods And Compositions Involving S-Ship Promoter Regions
|
|
RU2381234C2
(ru)
|
2004-05-28 |
2010-02-10 |
Эдженсис, Инк. |
Антитела и родственные молекулы, связывающиеся с белками psca
|
|
US20090221440A1
(en)
*
|
2004-07-12 |
2009-09-03 |
Board Of Regents, The University Of Texas System |
Methods and compositions related to identifying protein-protein interactions
|
|
US7572600B2
(en)
|
2004-08-04 |
2009-08-11 |
Chemocentryx, Inc. |
Enzymatic activities in chemokine-mediated inflammation
|
|
ES2534300T3
(es)
|
2004-11-12 |
2015-04-21 |
Asuragen, Inc. |
Procedimientos y composiciones que implican miARN y moléculas inhibidoras de miARN
|
|
BRPI0518933A2
(pt)
|
2004-11-16 |
2008-12-16 |
Crucell Holland B V E Aeras Gl |
adenovÍrus recombinante defeituoso de replicaÇço, vetor de polinucleotÍdeo recombinante, vacina multivalente da tuberculose, e, uso do antÍgeno tb10.4 de mycobacterium
|
|
CA2587507C
(en)
*
|
2004-12-01 |
2013-11-19 |
Aeras Global Tb Vaccine Foundation |
Electroporation of mycobacterium and overexpression of antigens in mycobacteria
|
|
US20080254059A1
(en)
*
|
2005-02-11 |
2008-10-16 |
Bett Andrew J |
Adenovirus Serotype 26 Vectors, Nucleic Acid and Viruses Produced Thereby
|
|
DK2325306T3
(en)
|
2005-02-25 |
2014-03-03 |
Oncotherapy Science Inc |
Peptide vaccines against lung cancers expressing TTK, URLC10 or KOC1 polypeptide
|
|
EP2289532A1
(de)
|
2005-02-28 |
2011-03-02 |
Oncotherapy Science, Inc. |
Epitop Peptide, die vom Vascular Endothelial Growth Factor Rezeptor 1 abgeleitet wurden und Impfstoffe, die diese enthalten
|
|
EP3300739A3
(de)
|
2005-03-31 |
2018-07-18 |
Agensys, Inc. |
An 161p2f10b-proteine bindende antikörper und zugehörige moleküle
|
|
AU2006272555B2
(en)
|
2005-07-25 |
2012-03-08 |
Aptevo Research And Development Llc |
B-cell reduction using CD37-specific and CD20-specific binding molecules
|
|
JP5095603B2
(ja)
|
2005-07-27 |
2012-12-12 |
オンコセラピー・サイエンス株式会社 |
結腸癌関連遺伝子tom34
|
|
WO2007021886A2
(en)
*
|
2005-08-10 |
2007-02-22 |
Oklahoma Medical Research Foundation |
Truncated memapsin 2 for use for treating alzheimer's disease
|
|
US8980246B2
(en)
|
2005-09-07 |
2015-03-17 |
Sillajen Biotherapeutics, Inc. |
Oncolytic vaccinia virus cancer therapy
|
|
EP1933857A2
(de)
*
|
2005-09-07 |
2008-06-25 |
Jennerex Biotherapeutics ULC |
Systemische behandlung von metastasierten und/oder systemisch dissemierten tumoren mit gm-csf-exprimierenden pockenviren
|
|
US7919258B2
(en)
*
|
2005-10-07 |
2011-04-05 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Rapid tuberculosis detection method
|
|
AU2007281934B2
(en)
|
2006-01-18 |
2012-11-15 |
University Of Chicago |
Compositions and methods related to Staphylococcal bacterium proteins
|
|
WO2007106536A2
(en)
*
|
2006-03-14 |
2007-09-20 |
Oregon Health & Science University |
Methods for producing an immune response to tuberculosis
|
|
GB0605474D0
(en)
*
|
2006-03-17 |
2006-04-26 |
Isis Innovation |
Clinical correlates
|
|
CN105837690A
(zh)
*
|
2006-06-12 |
2016-08-10 |
新兴产品开发西雅图有限公司 |
具有效应功能的单链多价结合蛋白
|
|
CN100503824C
(zh)
*
|
2006-07-20 |
2009-06-24 |
武汉大学 |
抗结核杆菌感染的小分子核苷酸dna适配子及其制备方法
|
|
US20100055113A1
(en)
|
2006-07-27 |
2010-03-04 |
The University Of Maryland, Baltimore |
Cellular receptor for antiproliferative factor
|
|
WO2009016433A2
(en)
|
2006-09-15 |
2009-02-05 |
Ottawa Health Research Institute |
Oncolytic rhabdovirus
|
|
CA2915560A1
(en)
|
2006-10-17 |
2008-04-24 |
Tomoaki Fujioka |
Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides
|
|
EP2087096A4
(de)
*
|
2006-10-20 |
2009-11-25 |
Univ Arizona |
Modifizierte cyanobakterien
|
|
DK2102239T3
(da)
|
2006-11-30 |
2012-05-29 |
Res Dev Foundation |
Forbedrede immunoglobulin-biblioteker
|
|
TWI494319B
(zh)
|
2007-02-21 |
2015-08-01 |
Oncotherapy Science Inc |
表現腫瘤相關抗原之癌症的胜肽疫苗
|
|
KR20080084528A
(ko)
|
2007-03-15 |
2008-09-19 |
제네렉스 바이오테라퓨틱스 인크. |
종양살상형 백시니아 바이러스 암 치료
|
|
TW201425333A
(zh)
|
2007-04-11 |
2014-07-01 |
Oncotherapy Science Inc |
腫瘤血管內皮標誌8胜肽及包含此胜肽之疫苗
|
|
US8629245B2
(en)
|
2007-05-01 |
2014-01-14 |
Research Development Foundation |
Immunoglobulin Fc libraries
|
|
WO2009023386A2
(en)
*
|
2007-07-06 |
2009-02-19 |
Trubion Pharmaceuticals, Inc. |
Binding peptides having a c-terminally disposed specific binding domain
|
|
KR20100072228A
(ko)
|
2007-08-31 |
2010-06-30 |
유니버시티 오브 시카고 |
스타필로코커스 폐 질환 및 상태에 대한 면역화와 관련된 방법 및 조성물
|
|
EP3085707B1
(de)
|
2007-11-01 |
2019-02-27 |
Mayo Foundation for Medical Education and Research |
Hla-dr-bindende peptide und deren anwendungen
|
|
WO2009102509A2
(en)
|
2008-01-10 |
2009-08-20 |
Research Development Foundation |
Vaccines and diagnostics for the ehrlichioses
|
|
AU2009207923A1
(en)
*
|
2008-01-23 |
2009-07-30 |
Rigshospitalet |
Classification of individuals suffering from cardiovascular diseases according to survival prognoses as found by measuring the levels of biomarker YKL-40
|
|
EP2245464B1
(de)
|
2008-01-25 |
2016-12-14 |
MultiVir Inc. |
P53-biomarker
|
|
JP5951254B2
(ja)
|
2008-03-17 |
2016-07-13 |
ザ スクリプス リサーチ インスティテュート |
人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
|
|
WO2009117134A2
(en)
*
|
2008-03-21 |
2009-09-24 |
National Institutes Of Health |
Aerosolized genetic vaccines and methods of use
|
|
NZ603059A
(en)
*
|
2008-04-11 |
2014-07-25 |
Emergent Product Dev Seattle |
Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof
|
|
US9650639B2
(en)
|
2008-05-19 |
2017-05-16 |
Advaxis, Inc. |
Dual delivery system for heterologous antigens
|
|
JP5757863B2
(ja)
|
2008-05-19 |
2015-08-05 |
アドバクシス インコーポレイテッド |
異種抗原のための二重送達システム
|
|
US9017660B2
(en)
|
2009-11-11 |
2015-04-28 |
Advaxis, Inc. |
Compositions and methods for prevention of escape mutation in the treatment of Her2/neu over-expressing tumors
|
|
ES2587395T3
(es)
|
2008-06-04 |
2016-10-24 |
Cellular Dynamics International, Inc. |
Procedimientos para la producción de células IPS usando un enfoque no vírico
|
|
KR101598876B1
(ko)
*
|
2008-07-25 |
2016-03-02 |
디파트먼트 오브 바이오테크놀러지 |
리슈마니아증 및 결핵에 대한 백신 개발을 위한 dna 키메라의 작제
|
|
WO2010019569A1
(en)
|
2008-08-12 |
2010-02-18 |
Cellular Dynamics International. Inc. |
Methods for the production of ips cells
|
|
CA2734325A1
(en)
|
2008-08-18 |
2010-02-25 |
University Of Maryland, Baltimore |
Derivatives of apf and methods of use
|
|
JP5764822B2
(ja)
|
2008-08-27 |
2015-08-19 |
オンコセラピー・サイエンス株式会社 |
がんの治療および診断の標的遺伝子としてのprmt1
|
|
US20110262477A1
(en)
|
2008-10-06 |
2011-10-27 |
University Of Chicago |
Compositions and Methods Related to Bacterial EAP, EMP, and/or ADSA Proteins
|
|
EP2352747A1
(de)
*
|
2008-10-23 |
2011-08-10 |
Intervet International BV |
Lawsonia-intrazellularis-impfstoffe
|
|
TWI539160B
(zh)
|
2008-12-05 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Wdrpuh抗原決定位胜肽以及含此胜肽之疫苗
|
|
EP2370568B1
(de)
|
2008-12-10 |
2017-07-19 |
Dana-Farber Cancer Institute, Inc. |
Mek mutanten mit resistenz gegen mek inhibitoren
|
|
SG172160A1
(en)
|
2008-12-17 |
2011-07-28 |
Scripps Research Inst |
Generation and maintenance of stem cells
|
|
EP2379720B1
(de)
|
2009-01-20 |
2016-08-17 |
Alona Zilberberg |
Durch den promoter mir-21 angetriebene gezielte krebstherapie
|
|
TWI469791B
(zh)
|
2009-02-18 |
2015-01-21 |
Oncotherapy Science Inc |
Foxm1胜肽以及含此胜肽之疫苗
|
|
KR101744514B1
(ko)
|
2009-03-18 |
2017-06-08 |
온코세라피 사이언스 가부시키가이샤 |
Neil3 펩티드 및 이를 포함하는 백신
|
|
HRP20160274T1
(hr)
|
2009-04-03 |
2016-04-08 |
University Of Chicago |
Pripravci i metode vezane za varijante proteina a (spa)
|
|
ES2568938T3
(es)
|
2009-04-28 |
2016-05-05 |
Vanderbilt University |
Composiciones y procedimientos de tratamiento de trastornos que implican apoptosis de células epiteliales
|
|
TWI507204B
(zh)
|
2009-05-26 |
2015-11-11 |
Oncotherapy Science Inc |
Cdc45l胜肽與含此胜肽之疫苗
|
|
CN105925535A
(zh)
|
2009-06-05 |
2016-09-07 |
细胞动力国际有限公司 |
重编程t细胞和造血细胞的方法
|
|
EP2470653A1
(de)
|
2009-08-26 |
2012-07-04 |
Research Development Foundation |
Verfahren zur erstellung von antikörperbibliotheken
|
|
KR101838472B1
(ko)
|
2009-09-14 |
2018-03-15 |
신라젠(주) |
종양 용해 백시니아 바이러스 병용 암 치료요법
|
|
US9175070B2
(en)
|
2009-09-25 |
2015-11-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Neutralizing antibodies to HIV-1 and their use
|
|
JP2013506682A
(ja)
*
|
2009-09-30 |
2013-02-28 |
セント ルイス ユニバーシティ |
異種亜型インフルエンザt細胞応答を誘発するためのペプチド
|
|
MX389666B
(es)
|
2009-10-16 |
2025-03-19 |
Scripps Research Inst |
Induccion de celulas pluripotentes.
|
|
US10016617B2
(en)
|
2009-11-11 |
2018-07-10 |
The Trustees Of The University Of Pennsylvania |
Combination immuno therapy and radiotherapy for the treatment of Her-2-positive cancers
|
|
WO2011070440A2
(en)
|
2009-12-10 |
2011-06-16 |
Ottawa Hospital Research Institute |
Oncolytic rhabdovirus
|
|
TW201136604A
(en)
|
2009-12-14 |
2011-11-01 |
Oncotherapy Science Inc |
TMEM22 peptides and vaccines including the same
|
|
WO2011100508A2
(en)
|
2010-02-12 |
2011-08-18 |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
Methods and compositions related to glycoprotein-immunoglobulin fusions
|
|
CA2789696C
(en)
|
2010-02-25 |
2017-11-07 |
Dana-Farber Cancer Institute, Inc. |
Braf mutations conferring resistance to braf inhibitors
|
|
WO2011106705A2
(en)
|
2010-02-26 |
2011-09-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Dna-protein vaccination protocols
|
|
EP3214174B1
(de)
|
2010-03-04 |
2019-10-16 |
InteRNA Technologies B.V. |
Mirna-molekül, das über seine quelle definiert ist, und seine diagnostischen und therapeutischen verwendungen bei mit emt assoziierten krankheiten
|
|
US8933014B2
(en)
|
2010-03-11 |
2015-01-13 |
Oncotherapy Science, Inc. |
HJURP peptides and vaccines including the same
|
|
CA2800498C
(en)
|
2010-03-31 |
2021-11-16 |
The Scripps Research Institute |
Reprogramming cells
|
|
TWI538685B
(zh)
|
2010-04-02 |
2016-06-21 |
腫瘤療法 科學股份有限公司 |
Ect2胜肽及含此胜肽之疫苗
|
|
EP2555794A4
(de)
|
2010-04-05 |
2014-01-15 |
Univ Chicago |
Zusammensetzungen und verfahren im zusammenhang mit protein-a-(spa)-antikörpern als immunreaktionsverstärker
|
|
WO2011126976A1
(en)
|
2010-04-07 |
2011-10-13 |
Vanderbilt University |
Reovirus vaccines and methods of use therefor
|
|
US8785385B2
(en)
|
2010-04-19 |
2014-07-22 |
Research Development Foundation |
RTEF-1 variants and uses thereof
|
|
EP2580322B1
(de)
|
2010-06-09 |
2018-01-10 |
Dana-Farber Cancer Institute, Inc. |
Mek-1-mutation für resistenz gegenüber raf- und mek-hemmern
|
|
WO2011159726A2
(en)
|
2010-06-14 |
2011-12-22 |
The Scripps Research Institute |
Reprogramming of cells to a new fate
|
|
CA2802249A1
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
|
WO2011159797A2
(en)
|
2010-06-15 |
2011-12-22 |
Cellular Dynamics International, Inc. |
A compendium of ready-built stem cell models for interrogation of biological response
|
|
AU2011274367B2
(en)
|
2010-07-02 |
2015-04-23 |
The University Of Chicago |
Compositions and methods related to protein A (SpA) variants
|
|
EP2591106A1
(de)
|
2010-07-06 |
2013-05-15 |
InteRNA Technologies B.V. |
Mirna und ihre diagnostischen und therapeutischen verwendungen für mit melanomen assoziierte erkrankungen oder leiden oder für mit dem aktivierten braf-pfad assoziierte erkrankungen oder leiden
|
|
JP5897002B2
(ja)
|
2010-07-07 |
2016-04-13 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
プログラミングによる内皮細胞の産生
|
|
EP2601289B1
(de)
|
2010-08-04 |
2017-07-12 |
Cellular Dynamics International, Inc. |
Neuprogrammierung immortalisierter b-zellen
|
|
JP5793194B2
(ja)
|
2010-09-09 |
2015-10-14 |
ザ・ユニバーシティ・オブ・シカゴThe University Of Chicago |
感染防御ブドウ球菌抗原が関与する方法および組成物
|
|
JP6124791B2
(ja)
|
2010-09-22 |
2017-05-10 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド,ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO,a body corporate |
Smad7の治療的適用
|
|
CN107412756A
(zh)
|
2010-10-01 |
2017-12-01 |
宾夕法尼亚大学理事会 |
李斯特菌疫苗载体用于在寄生虫感染的个体中扭转免疫无应答的用途
|
|
AU2011308567B2
(en)
|
2010-10-01 |
2015-09-03 |
Fundacion Centro Nacional De Investigaciones Oncologicas, Carlos Iii |
Manipulation of stem cell function by p53 isoforms
|
|
US9732319B2
(en)
|
2010-12-22 |
2017-08-15 |
Fate Therapeutics, Inc. |
Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
|
|
US9919047B2
(en)
|
2011-01-04 |
2018-03-20 |
Sillajen, Inc. |
Generation of antibodies to tumor antigens and generation of tumor specific complement dependent cytotoxicity by administration of oncolytic vaccinia virus
|
|
EP2474617A1
(de)
|
2011-01-11 |
2012-07-11 |
InteRNA Technologies BV |
MIR zur Behandlung von Neoangiogenese
|
|
RU2539035C2
(ru)
*
|
2011-01-13 |
2015-01-10 |
Амир Закиевич Максютов |
Профилактическая или терапевтическая полиэпитопная противотуберкулезная вакцинная конструкция, обеспечивающая индукцию клеточного иммунного ответа cd4+ или cd8+ т-лимфоцитов
|
|
CA2826467C
(en)
|
2011-02-07 |
2019-11-12 |
Research Development Foundation |
Engineered immunoglobulin fc polypeptides
|
|
WO2012109208A2
(en)
|
2011-02-08 |
2012-08-16 |
Cellular Dynamics International, Inc. |
Hematopoietic precursor cell production by programming
|
|
CA2829960A1
(en)
|
2011-03-11 |
2012-09-20 |
John Rothman |
Listeria-based adjuvants
|
|
EP2694534B1
(de)
|
2011-04-08 |
2018-06-20 |
Evaxion Biotech ApS |
Proteine und nukleinsäuren zur verwendung für impstoffe gegen staphylococcus aureus
|
|
US8945588B2
(en)
|
2011-05-06 |
2015-02-03 |
The University Of Chicago |
Methods and compositions involving protective staphylococcal antigens, such as EBH polypeptides
|
|
EP2710130B1
(de)
|
2011-05-19 |
2022-06-29 |
Fundación Pública Andaluza Progreso Y Salud |
Effizient induzierbare lentivirale tet-on-vektor system mit zwei-promotoren
|
|
EP2718427B1
(de)
|
2011-06-08 |
2017-01-11 |
Children's Hospital of Eastern Ontario Research Institute Inc. |
Zusammensetzungen zur behandlung von glioblastomen
|
|
WO2013009825A1
(en)
|
2011-07-11 |
2013-01-17 |
Cellular Dynamics International, Inc. |
Methods for cell reprogramming and genome engineering
|
|
DK2738255T3
(en)
|
2011-07-29 |
2017-03-06 |
Univ Tokushima |
ERAP1-Derived Peptide and its Use
|
|
US9458447B2
(en)
|
2011-08-12 |
2016-10-04 |
Oncotherapy Science, Inc. |
MPHOSPH1 peptides and vaccines including the same
|
|
US9556281B2
(en)
|
2011-08-15 |
2017-01-31 |
The University Of Chicago |
Compositions and methods related to antibodies to staphylococcal protein A
|
|
US20130101664A1
(en)
|
2011-08-18 |
2013-04-25 |
Donald W. Kufe |
Muc1 ligand traps for use in treating cancers
|
|
JP2013046596A
(ja)
*
|
2011-08-29 |
2013-03-07 |
Alpha-Nano-Medica Co Ltd |
新規な複合体、それを含有する医薬及び癌の治療方法
|
|
EP2766388A1
(de)
|
2011-10-12 |
2014-08-20 |
Møller, Niels Iversen |
Peptide aus campylobacter jejuni und ihre verwendung bei der impfung
|
|
RU2633503C2
(ru)
|
2011-10-28 |
2017-10-12 |
Онкотерапи Сайенс, Инк. |
Пептиды торк и содержащие их вакцины
|
|
EP3369818B1
(de)
|
2011-12-22 |
2021-06-09 |
InteRNA Technologies B.V. |
Mirna zur behandlung von kopf-hals-karzinom
|
|
BR112014022662A2
(pt)
|
2012-03-12 |
2017-10-03 |
Advaxis Inc |
Inibição da função de célula supressora seguindo tratamento de vacina de listeria
|
|
WO2013162746A1
(en)
|
2012-04-26 |
2013-10-31 |
University Of Chicago |
Staphylococcal coagulase antigens and methods of their use
|
|
AU2013252888B2
(en)
|
2012-04-26 |
2018-06-14 |
University Of Chicago |
Compositions and methods related to antibodies that neutralize coagulase activity during Staphylococcus aureus disease
|
|
WO2014010231A1
(en)
|
2012-07-10 |
2014-01-16 |
Oncotherapy Science, Inc. |
Kif20a epitope peptides for th1 cells and vaccines containing the same
|
|
EP2872531A4
(de)
|
2012-07-10 |
2016-04-06 |
Oncotherapy Science Inc |
Ly6k-epitopenpeptide für th1-zellen sowie impfstoffe damit
|
|
JP6283861B2
(ja)
|
2012-09-11 |
2018-02-28 |
オンコセラピー・サイエンス株式会社 |
Ube2tペプチドおよびそれを含むワクチン
|
|
EP2912058A1
(de)
|
2012-10-23 |
2015-09-02 |
The Board of Regents of The University of Texas System |
Antikörper mit manipulierten igg-fc-domänen
|
|
US10201556B2
(en)
|
2012-11-06 |
2019-02-12 |
Interna Technologies B.V. |
Combination for use in treating diseases or conditions associated with melanoma, or treating diseases or conditions associated with activated B-raf pathway
|
|
WO2014116721A1
(en)
|
2013-01-22 |
2014-07-31 |
The Arizona Board Of Regents For And On Behalf Of Arizona State University |
Geminiviral vector for expression of rituximab
|
|
MX2015010841A
(es)
|
2013-02-20 |
2016-05-09 |
Regeneron Pharma |
Modificacion genetica de ratas.
|
|
RU2019107976A
(ru)
|
2013-02-21 |
2019-08-23 |
Тёрнстоун Лимитед Партнершип |
Композиция вакцины
|
|
CN105229144A
(zh)
|
2013-02-22 |
2016-01-06 |
细胞动力学国际有限公司 |
通过组合的遗传工程和化学工程经由正向编程产生肝细胞
|
|
EP2961386B1
(de)
|
2013-02-28 |
2019-07-10 |
The General Hospital Corporation |
Mirna-profilierungszusammensetzungen und verfahren zur verwendung
|
|
US9422352B2
(en)
|
2013-03-08 |
2016-08-23 |
The Regents Of The University Of Colorado, A Body Corporate |
PTD-SMAD7 therapeutics
|
|
TWI658049B
(zh)
|
2013-03-12 |
2019-05-01 |
腫瘤療法 科學股份有限公司 |
Kntc2胜肽及含此胜肽之疫苗
|
|
US9809801B2
(en)
*
|
2013-03-15 |
2017-11-07 |
Université De Genève |
Anti-mycobacterial vaccines
|
|
WO2014153636A1
(en)
|
2013-03-27 |
2014-10-02 |
Immunovaccine Technologies Inc. |
Method for improving the efficacy of a survivin vaccine in the treatment of cancer
|
|
RU2520078C1
(ru)
*
|
2013-04-25 |
2014-06-20 |
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "НИИЭМ им. Н.Ф. Гамалеи" Минздрава России) |
СПОСОБ ПОЛУЧЕНИЯ ИММУНОГЕННОЙ КОМПОЗИЦИИ НА ОСНОВЕ ГИБРИДНОГО БЕЛКА Ag85A-DBD И ДЕКСТРАНА, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pAg85A-DBD, ШТАММ Escherichia coli [pREP4, pAg85A-DBD], ХИМЕРНЫЙ БЕЛОК Ag85A-DBD
|
|
EP4786600A2
(de)
|
2013-09-09 |
2026-08-05 |
FibroBiologics, Inc. |
Gentherapie zur regeneration von chondrozyten oder knorpelzellen
|
|
US20170002064A1
(en)
|
2013-11-08 |
2017-01-05 |
The Board Of Regents Of The University Of Texas System |
Vh4 antibodies against gray matter neuron and astrocyte
|
|
US10028902B2
(en)
|
2013-11-08 |
2018-07-24 |
Baylor Research Institute |
Nuclear localization of GLP-1 stimulates myocardial regeneration and reverses heart failure
|
|
EP3077820B1
(de)
|
2013-12-03 |
2025-02-26 |
Evaxion Biotech A/S |
Proteine und nukleinsäuren zur verwendung für impfstoffe gegen staphylococcus aureus
|
|
CN106132992B
(zh)
|
2014-01-29 |
2020-08-07 |
达娜-法勃肿瘤研究所公司 |
针对muc1-c/胞外结构域(muc1-c/ecd)的抗体
|
|
EP3105332A4
(de)
|
2014-02-14 |
2018-01-10 |
University of Utah Research Foundation |
Verfahren und zusammensetzungen zur hemmung von frühgeborenen-retinopathie
|
|
WO2015130783A1
(en)
|
2014-02-25 |
2015-09-03 |
Research Development Foundation |
Sty peptides for inhibition of angiogenesis
|
|
CN120536341A
(zh)
|
2014-03-04 |
2025-08-26 |
菲特治疗公司 |
改良的重编程方法和细胞培养平台
|
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
|
JP6700512B2
(ja)
|
2014-08-04 |
2020-05-27 |
オンコセラピー・サイエンス株式会社 |
Cdca1由来ペプチドおよびそれを含むワクチン
|
|
EP3178838B1
(de)
|
2014-08-04 |
2019-09-18 |
OncoTherapy Science, Inc. |
Koc1-abgeleitetes peptid und impfstoff damit
|
|
US10576097B2
(en)
|
2014-08-04 |
2020-03-03 |
Oncotherapy Science, Inc. |
URLC10-derived peptide and vaccine containing same
|
|
US20180363070A9
(en)
|
2014-08-12 |
2018-12-20 |
Univ Wayne State |
Systems and methods to detect stem cell stress and uses thereof
|
|
EP3777883A1
(de)
|
2014-11-13 |
2021-02-17 |
Evaxion Biotech ApS |
Aus acinetobacter baumannii abgeleitete peptide und deren verwendung bei der impfung
|
|
WO2016109880A1
(en)
|
2015-01-06 |
2016-07-14 |
Immunovaccine Technologies Inc. |
Lipid a mimics, methods of preparation, and uses thereof
|
|
EP3485907B1
(de)
|
2015-01-12 |
2023-06-28 |
Evaxion Biotech ApS |
Behandlung und prophylaxe von k.-pneumoniae-infektionen
|
|
US20180002656A1
(en)
|
2015-01-28 |
2018-01-04 |
Sabic Global Technologies B.V. |
Methods and compositions for high-efficiency production of biofuel and/or biomass
|
|
JP6724023B2
(ja)
|
2015-02-09 |
2020-07-15 |
リサーチ ディベロップメント ファウンデーション |
改善された補体活性化を示す操作された免疫グロブリンfcポリペプチド
|
|
WO2016134293A1
(en)
|
2015-02-20 |
2016-08-25 |
Baylor College Of Medicine |
p63 INACTIVATION FOR THE TREATMENT OF HEART FAILURE
|
|
ES2959642T3
(es)
|
2015-05-13 |
2024-02-27 |
The Us Secretary Of The Department Of Health And Human Services |
Metodos y composiciones para inducir una respuesta inmunitaria mediante construcciones con elementos conservados
|
|
WO2016196366A1
(en)
|
2015-05-29 |
2016-12-08 |
The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Extension of replicative lifespan in diseases of premature aging using p53 isoforms
|
|
EP4116316A1
(de)
|
2015-07-04 |
2023-01-11 |
Evaxion Biotech A/S |
Proteine und nukleinsäuren, die in impfstoffen gegen pseudomonas aeruginosa nützlich sind
|
|
US10526408B2
(en)
|
2015-08-28 |
2020-01-07 |
Research Development Foundation |
Engineered antibody FC variants
|
|
HK1251480A1
(zh)
|
2015-09-21 |
2019-02-01 |
Aptevo Research And Development Llc |
Cd3结合多肽
|
|
SG11201802881YA
(en)
|
2015-10-08 |
2018-05-30 |
Oncotherapy Science Inc |
Foxm1-derived peptide, and vaccine including same
|
|
CN117737124A
(zh)
|
2015-10-16 |
2024-03-22 |
菲特治疗公司 |
用于诱导和维护基态多能性的平台
|
|
WO2017070333A1
(en)
|
2015-10-20 |
2017-04-27 |
Cellular Dynamics International, Inc. |
Multi-lineage hematopoietic precursor cell production by genetic programming
|
|
KR102929174B1
(ko)
|
2015-10-30 |
2026-02-20 |
더 리전츠 오브 더 유니버시티 오브 캘리포니아 |
줄기세포로부터 t-세포를 생산하는 방법 및 상기 t-세포를 이용한 면역치료 방법
|
|
SI3370733T1
(sl)
|
2015-11-02 |
2021-11-30 |
Board Of Regents The University Of Texas System |
Postopek za aktivacijo CD40 in blokada imunske nadzorne točke
|
|
US20190038713A1
(en)
|
2015-11-07 |
2019-02-07 |
Multivir Inc. |
Compositions comprising tumor suppressor gene therapy and immune checkpoint blockade for the treatment of cancer
|
|
WO2017083296A1
(en)
|
2015-11-09 |
2017-05-18 |
The Children's Hospital Of Philadelphia |
Glypican 2 as a cancer marker and therapeutic target
|
|
US10946084B2
(en)
|
2016-02-22 |
2021-03-16 |
Evaxion Biotech Aps |
Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus
|
|
CA3019635A1
(en)
|
2016-03-31 |
2017-10-05 |
Baylor Research Institute |
Angiopoietin-like protein 8 (angptl8)
|
|
WO2017216384A1
(en)
|
2016-06-17 |
2017-12-21 |
Evaxion Biotech Aps |
Vaccination targeting ichthyophthirius multifiliis
|
|
AU2017280065B2
(en)
*
|
2016-06-22 |
2021-07-01 |
International Aids Vaccine Initiative, Inc. |
Recombinant cytomegalovirus vectors as vaccines for tuberculosis
|
|
WO2017220787A1
(en)
|
2016-06-24 |
2017-12-28 |
Evaxion Biotech Aps |
Vaccines against aearomonas salmonicida infection
|
|
AU2017290805B2
(en)
|
2016-07-01 |
2023-11-16 |
Research Development Foundation |
Elimination of proliferating cells from stem cell-derived grafts
|
|
US11414464B2
(en)
|
2016-07-22 |
2022-08-16 |
Evaxion Biotech A/S |
Chimeric proteins for inducing immunity towards infection with S. aureus
|
|
US9963498B2
(en)
|
2016-08-18 |
2018-05-08 |
Wisconsin Alumni Research Foundation |
Peptides that inhibit syndecan-1 activation of VLA-4 and IGF-1R
|
|
CA3039136A1
(en)
|
2016-09-02 |
2018-03-08 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
|
CA3038690A1
(en)
|
2016-10-05 |
2018-04-12 |
FUJIFILM Cellular Dynamics, Inc. |
Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
|
|
JP7212615B2
(ja)
|
2016-10-05 |
2023-01-25 |
フジフィルム セルラー ダイナミクス,インコーポレイテッド |
多能性幹細胞からhlaホモ接合免疫細胞への指向分化方法
|
|
WO2018111902A1
(en)
|
2016-12-12 |
2018-06-21 |
Multivir Inc. |
Methods and compositions comprising viral gene therapy and an immune checkpoint inhibitor for treatment and prevention of cancer and infectious diseases
|
|
EP3565576A1
(de)
|
2017-01-05 |
2019-11-13 |
Evaxion Biotech ApS |
Impfstoffe gegen pseudomonas aeruginosa
|
|
CN110891967B
(zh)
|
2017-04-18 |
2025-03-14 |
富士胶片细胞动力公司 |
抗原特异性免疫效应细胞
|
|
WO2018213679A1
(en)
|
2017-05-19 |
2018-11-22 |
Second Genome, Inc. |
Proteins for the treatment of epithelial barrier function disorders
|
|
AU2018358016A1
(en)
|
2017-11-03 |
2020-05-07 |
Interna Technologies B.V. |
MiRNA molecule, equivalent, antagomir, or source thereof for treating and/or diagnosing a condition and/or a disease associated with neuronal deficiency or for neuronal (re)generation
|
|
EP3710014A1
(de)
|
2017-11-14 |
2020-09-23 |
Henry Ford Health System |
Zusammensetzungen zur verwendung bei der behandlung und vorbeugung von kardiovaskulären störungen infolge von zerebrovaskulären verletzungen
|
|
JP2021509815A
(ja)
|
2018-01-05 |
2021-04-08 |
オタワ ホスピタル リサーチ インスティチュート |
改変ワクシニアベクター
|
|
WO2019145399A1
(en)
|
2018-01-24 |
2019-08-01 |
Evaxion Biotech Aps |
Vaccines for prophylaxis of s. aureus infections
|
|
CA3094329A1
(en)
|
2018-03-19 |
2020-02-20 |
Multivir Inc. |
Methods and compositions comprising tumor suppressor gene therapy and cd122/cd132 agonists for the treatment of cancer
|
|
US11649455B2
(en)
|
2018-03-30 |
2023-05-16 |
University Of Geneva |
Micro RNA expression constructs and uses thereof
|
|
TW202023581A
(zh)
|
2018-08-02 |
2020-07-01 |
日商腫瘤療法 科學股份有限公司 |
來自cdca1的胜肽及含有此的疫苗
|
|
KR20210102870A
(ko)
|
2018-08-30 |
2021-08-20 |
테나야 테라퓨틱스, 인코포레이티드 |
미오카르딘 및 ascl1을 사용한 심장 세포 재프로그래밍
|
|
WO2020069313A2
(en)
|
2018-09-28 |
2020-04-02 |
Henry Ford Health System |
Use of extracellular vesicles in combination with tissue plasminogen activator and/or thrombectomy to treat stroke
|
|
EP3870207A1
(de)
|
2018-10-22 |
2021-09-01 |
Evaxion Biotech ApS |
Impfstoff gegen m. catharrhalis
|
|
WO2020086927A1
(en)
|
2018-10-26 |
2020-04-30 |
Saint Louis University |
Peptides for inducing heterosubtypic influenza t cell responses
|
|
JP7525855B2
(ja)
|
2018-11-30 |
2024-07-31 |
国立大学法人徳島大学 |
Big3-phb2相互作用阻害phb2由来ペプチドを含む乳がん治療薬
|
|
WO2020171889A1
(en)
|
2019-02-19 |
2020-08-27 |
University Of Rochester |
Blocking lipid accumulation or inflammation in thyroid eye disease
|
|
EP3931206A1
(de)
|
2019-02-27 |
2022-01-05 |
Evaxion Biotech ApS |
Impfstoffe gegen h. influenzae
|
|
CA3139981A1
(en)
|
2019-05-14 |
2020-11-19 |
The University Of Chicago |
Methods and compositions comprising staphylococcus protein a (spa) variants
|
|
SG10201905939WA
(en)
|
2019-06-26 |
2021-01-28 |
Cell Mogrify Australia Pty Ltd |
Cell culture methods and compositions
|
|
EP3997226A1
(de)
|
2019-07-11 |
2022-05-18 |
Tenaya Therapeutics, Inc. |
Umprogrammierung von herzzellen mit mikrornas und anderen faktoren
|
|
JP2022541538A
(ja)
|
2019-07-19 |
2022-09-26 |
ザ・チルドレンズ・ホスピタル・オブ・フィラデルフィア |
グリピカン2結合ドメインを含有するキメラ抗原受容体
|
|
US20210147525A1
(en)
|
2019-10-18 |
2021-05-20 |
The Regents Of The University Of California |
Methods and compositions for treating pathogenic blood vessel disorders
|
|
KR102237349B1
(ko)
|
2019-10-23 |
2021-04-07 |
한국과학기술연구원 |
니코틴 중독 또는 금단 증상 예방 또는 치료용 약학 조성물
|
|
WO2021092657A1
(en)
|
2019-11-13 |
2021-05-20 |
Monash University |
Methods for reprogramming cells
|
|
WO2021113644A1
(en)
|
2019-12-05 |
2021-06-10 |
Multivir Inc. |
Combinations comprising a cd8+ t cell enhancer, an immune checkpoint inhibitor and radiotherapy for targeted and abscopal effects for the treatment of cancer
|
|
US20230050225A1
(en)
|
2020-01-06 |
2023-02-16 |
Evaxion Biotech A/S |
Vaccines targeting Neisseria gonorrhoeae
|
|
CN115552022A
(zh)
|
2020-03-02 |
2022-12-30 |
特纳亚治疗股份有限公司 |
由心肌细胞表达的微rna控制的基因载体
|
|
EP4127148A1
(de)
|
2020-03-25 |
2023-02-08 |
Erasmus University Rotterdam Medical Center |
Reportersystem zur radionuklidbildgebung
|
|
AU2021278356A1
(en)
|
2020-05-27 |
2022-11-03 |
Antion Biosciences Sa |
Adapter molecules to re-direct CAR T cells to an antigen of interest
|
|
IL298254A
(en)
|
2020-05-29 |
2023-01-01 |
Fujifilm Cellular Dynamics Inc |
Double layer of retinal pigment epithelium and photoreceptors and their uses
|
|
KR20230019453A
(ko)
|
2020-05-29 |
2023-02-08 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
망막 색소 상피 세포 및 광수용체의 이중 세포 응집체 및 이의 사용 방법
|
|
WO2022053130A1
(en)
|
2020-09-09 |
2022-03-17 |
Sid Alex Group, S.R.O. |
Antago-mir-155 for treatment of v-src, c-src-tyrosine kinase-induced cancers
|
|
CA3200661A1
(en)
|
2020-11-05 |
2022-05-12 |
Board Of Regents, The University Of Texas System |
Engineered t cell receptors targeting egfr antigens and methods of use
|
|
AU2021389671A1
(en)
|
2020-11-24 |
2023-06-22 |
Monash University |
Induced stem cells
|
|
WO2022173767A1
(en)
|
2021-02-09 |
2022-08-18 |
University Of Houston System |
Oncolytic virus for systemic delivery and enhanced anti-tumor activities
|
|
US20240122865A1
(en)
|
2021-02-19 |
2024-04-18 |
Pfizer Inc. |
Methods of Protecting RNA
|
|
AU2022270611A1
(en)
|
2021-05-03 |
2023-10-12 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature corneal endothelial cells
|
|
CA3217861A1
(en)
|
2021-05-07 |
2022-11-10 |
Astellas Institute For Regenerative Medicine |
Methods of generating mature hepatocytes
|
|
WO2022251443A1
(en)
|
2021-05-26 |
2022-12-01 |
FUJIFILM Cellular Dynamics, Inc. |
Methods to prevent rapid silencing of genes in pluripotent stem cells
|
|
CA3224564A1
(en)
|
2021-07-05 |
2023-01-12 |
Andreas Holm MATTSSON |
Vaccines targeting neisseria gonorrhoeae
|
|
WO2023089556A1
(en)
|
2021-11-22 |
2023-05-25 |
Pfizer Inc. |
Reducing risk of antigen mimicry in immunogenic medicaments
|
|
US20250177514A1
(en)
|
2022-01-28 |
2025-06-05 |
Pfizer Inc. |
Coronavirus antigen variants
|
|
US20230295661A1
(en)
|
2022-03-16 |
2023-09-21 |
University Of Houston System |
Persistent hsv gene delivery system
|
|
GB202205265D0
(en)
|
2022-04-11 |
2022-05-25 |
Mogrify Ltd |
Cell conversion
|
|
US20250288657A1
(en)
|
2022-05-04 |
2025-09-18 |
Evaxion Biotech A/S |
Staphylococcal protein variants and truncates
|
|
GB202206507D0
(en)
|
2022-05-04 |
2022-06-15 |
Antion Biosciences Sa |
Expression construct
|
|
WO2023239940A1
(en)
|
2022-06-10 |
2023-12-14 |
Research Development Foundation |
Engineered fcriib selective igg1 fc variants and uses thereof
|
|
US20240003871A1
(en)
|
2022-06-29 |
2024-01-04 |
FUJIFILM Cellular Dynamics, Inc. |
Ipsc-derived astrocytes and methods of use thereof
|
|
WO2024130212A1
(en)
|
2022-12-16 |
2024-06-20 |
Turnstone Biologics Corp. |
Recombinant vaccinia virus encoding one or more natural killer cell and t lymphocyte inhibitors
|
|
WO2024186630A1
(en)
|
2023-03-03 |
2024-09-12 |
Henry Ford Health System |
Use of extracellular vesicles for the treatment of cancer
|
|
GB202306619D0
(en)
|
2023-05-04 |
2023-06-21 |
Antion Biosciences Sa |
Cell
|
|
EP4770666A2
(de)
|
2023-09-01 |
2026-07-08 |
Children's Hospital Medical Center |
Identifizierung von zielmolekülen für die immuntherapie bei melanomen unter verwendung von aus spleissen stammenden neoantigenen
|
|
GB202402745D0
(en)
|
2024-02-27 |
2024-04-10 |
Antion Biosciences Sa |
Cell
|
|
GB202407725D0
(en)
|
2024-05-31 |
2024-07-17 |
Mogrify Ltd |
Cell conversion
|
|
GB202415089D0
(en)
|
2024-10-14 |
2024-11-27 |
Mogrify Ltd |
Cell conversion
|
|
GB202415862D0
(en)
|
2024-10-28 |
2024-12-11 |
Antion Biosciences Sa |
Intronic mirna
|